Equities

Medicamen Organics Ltd

MEDIORG:NSI

Medicamen Organics Ltd

Actions
  • Price (INR)66.00
  • Today's Change2.00 / 3.13%
  • Shares traded8.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:56 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments294042
Total Receivables, Net18210566
Total Inventory616147
Prepaid expenses0.440.131.17
Other current assets, total--0.070.07
Total current assets273206156
Property, plant & equipment, net10598103
Goodwill, net------
Intangibles, net0.100.190.11
Long term investments------
Note receivable - long term4.662.482.38
Other long term assets3.07(0.11)--
Total assets386307261
LIABILITIES
Accounts payable719077
Accrued expenses------
Notes payable/short-term debt555244
Current portion long-term debt/capital leases706048
Other current liabilities, total236.591.85
Total current liabilities218209171
Total long term debt1.615.549.81
Total debt127118102
Deferred income tax123.353.14
Minority interest------
Other liabilities, total2.152.162.30
Total liabilities234220187
SHAREHOLDERS EQUITY
Common stock866060
Additional paid-in capital------
Retained earnings (accumulated deficit)662715
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1528775
Total liabilities & shareholders' equity386307261
Total common shares outstanding121212
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.